Vaccine-based clinical protection against SARS-CoV-2 infection and the humoral immune response: A 1-year follow-up study of patients with multiple sclerosis receiving ocrelizumab
Saskia Räuber(University of Münster), David Kremer(Heinrich Heine University Düsseldorf), Philipp Albrecht(Heinrich Heine University Düsseldorf), Melanie Korsen(Heinrich Heine University Düsseldorf), Christina B. Schroeter(University of Münster), Niklas Huntemann(University Hospital Münster), Sven G. Meuth(University of Würzburg), Marius Ringelstein(Heinrich Heine University Düsseldorf), Tristan Kölsche(Heinrich Heine University Düsseldorf), Liesa Regner-Nelke(Heinrich Heine University Düsseldorf), Orhan Aktaş(Heinrich Heine University Düsseldorf), Tobias Ruck(University Hospital Münster), Moritz Förster(Heinrich Heine University Düsseldorf), Christopher Nelke(University of Münster), Benedikt Plaack(Heinrich Heine University Düsseldorf), Hans‐Peter Hartung(The University of Sydney), Alice Willison(Düsseldorf University Hospital), Nico Melzer(University of Würzburg), Michael Barnett(The University of Sydney), Kristin S. Golombeck(University of Münster), Leoni Rolfes(University Hospital Münster), Julia Schüller(Heinrich Heine University Düsseldorf)
Cited by 9
Related Papers
Effects of dimethyl fumarate on neuroprotection and immunomodulation
|Journal of Neuroinflammation|2012|223
APOSTEL 2.0 Recommendations for Reporting Quantitative Optical Coherence Tomography Studies
|Neurology|2021|217
Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid
|Immunity|2020|187
Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells
|Nature Communications|2016|122
Retinal ganglion cell loss in neuromyelitis optica: a longitudinal study
|Journal of Neurology Neurosurgery & Psychiatry|2018|115